Shares of Portola Pharmaceuticals Inc. PTLA, -40.34% tumbled 45% in trading on Friday after the company shared "disappointing" preliminary fourth-quarter revenue for Andexxa, its antidote for patients treated with anticoagulants.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,